Expression of KL-6 antigen on leukemia cells of a patient with chronic myelocytic leukemia in blastic phase.
Takubo
T
T
Department of Clinical and Laboratory Medicine, Osaka City University Medical School, Osaka, Japan. m3542254@med.osaka-cu.ac.jp
Fujino
H
H
Hino
M
M
Yamane
T
T
Ohta
K
K
Koh
K R
KR
Kumura
T
T
Hashimoto
S
S
Nakao
T
T
Nakamae
H
H
Aoyama
Y
Y
Nishiki
S
S
Kinoshita
Y
Y
Kamitani
T
T
Tatsumi
N
N
Hojo
S
S
Fujita
J
J
D000941:Antigens / Q000097:blood* / Q000235:genetics; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor / Q000097:blood; D001752:Blast Crisis / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology; D001854:Bone Marrow Cells / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D006023:Glycoproteins / Q000097:blood* / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology*; D009000:Monocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018396:Mucin-1; D009077:Mucins; D012333:RNA, Messenger / Q000097:blood; D012334:RNA, Neoplasm / Q000097:blood; D020133:Reverse Transcriptase Polymerase Chain Reaction
D000941:Antigens; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D012333:RNA, Messenger; D012334:RNA, Neoplasm